Cochlear | COH - 市值

金融业

AUD

AUD 2.79B

现金及等价物

AUD 275.7M

AUD 319.2M

AUD 1.37B

AUD 558.9M

AUD 235.7M

股息收益率

1.17

AUD 261.1M

AUD 306.4M

5.5K

EPS每股收益

AUD 3.13

股本和储备

AUD 1.94B

AUD 856.8M

债务利息支出

AUD 6.3M

AUD 7.4M

AUD 200M

AUD 7.34B

AUD 161.5M

AUD 914.9M

AUD 261.1M

普通股股本

AUD 65.4M

43.67

AUD 121.1M

AUD 1.18B

销售和管理费用

AUD 449.4M

AUD 499.4M

贸易债权人

AUD 281.3M

应收帐款人

AUD 568.4M

	市值	更改		日
Ansell	USD 3.36B		450.92M	2025-12
Avita Medical	AUD 105.47M		35.32M	2025-12
Cochlear	AUD 17.05B		2.6B	2025-12
CSL	USD 55.89B		20.42B	2025-12
Fisher Paykel Healthcare	NZD 22.6B		636.38M	2026-07
Integral Diagnostics	AUD 1.08B		457.31M	2024-12
Mayne Pharma	AUD 252.67M		153.55M	2025-12
Mesoblast	USD 2.33B		936.82M	2025-12
Monash IVF	AUD 286.38M		11.69M	2025-12
Nanosonics	AUD 1.2B		25.43M	2025-12
Polynovo	AUD 849.74M		24.18M	2025-12
Ramsay Health Care	AUD 7.93B		537.83M	2025-12
Regis Healthcare	AUD 2.1B		260.38M	2025-12
ResMed	USD 29.75B		17.81B	2026-07
Sigma Healthcare	AUD 2.7B		1.98B	2026-07
Somnomed	AUD 79.04M		27.72M	2023-06
Sonic Healthcare	AUD 11.17B		1.7B	2025-12
Telix Pharmaceuticals	AUD 5.07B		5.81B	2025-12